Detection of cervical human papillomavirus infection by in situ hybridization in fetuses from women with squamous intraepithelial lesions

Journal of Lower Genital Tract Disease

Volumn 9, Issue 2, 2005, Pages 114-117

  Bruck, Lance R ^a,b   Zee, Sui ^a   Poulos, Brad ^a   Carroll, David ^a   Abadi, Maria ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b JACOBI MEDICAL CENTER   (United States)

Author keywords

Cervix; Fetus; HPV; In situ hybridization; Squamous intraepithelial lesion

Indexed keywords

FORMALDEHYDE; PARAFFIN; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; EXPOSURE; FETUS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTRAUTERINE INFECTION; PATHOGENESIS; SQUAMOUS CELL; UTERINE CERVIX EPITHELIUM; UTERINE CERVIX TUMOR; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DISEASE TRANSMISSION, VERTICAL; DNA, VIRAL; FEMALE; FETUS; HUMANS; IN SITU HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 16244382578     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/00128360-200504000-00008     Document Type: Article

References (16)

1. Stjernsw J. Cervical cancer: vaccine among the best prospects for prevention. WHO Press Release 1994:26.
2. Turek LP, Smith EM. Human Papillomavirus II. The genetic program of genital human papillomaviruses in infection and cancer. Obstet Gynecol Clin 1996;23:736-58.
3. Chesson HW, Blandford JM, Gift TL, Tao G, Irwin KL. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Prospectives on Sexual and Reproductive Health 2004;36:11-9.
4. Arena S, Marconi M, Ubertosi M, Frega A, Arena G, Villani G. HPV and pregnancy: diagnostic methods, transmission and evolution. Minerva Ginecol 2002;54:225-37.
5. Kawana K, Yasugi T, Yoshikawa H, Kawana Y, Matsumoto K, Nagawaka S, et al. Evidence for the presence of neutralizing antibodies against human papillomavirus type 6 in infants born to mothers with condyloma acuminata. Am J Perinatol 2003;20:11-6.
6. Yoshpe NS. Oral and laryngeal papilloma: a pediatric manifestation of sexually transmitted disease? Int J Pediatr Otorhinolaryngol 1995;31:77-83.
7. Armbruster-Moraes E, Ioshimoto LM, Leao E, Zugaib M. Presence of human papillomavirus DNA in amniotic fluids of pregnant women with cervical lesions. Gynecol Oncol 1994-54:152-8.
8. Tseng CJ, Lin CY, Wang RL, Chen LJ, Chang YL, Hsieh TT, et al. Possible transplacental transmission of human papillomaviruses. Am J Obstet Gynecol 1992;166:35-40.
9. Hermonat PL, Han L, Wendel PJ, Quirk JG, Stern S, Lowery CL, et al. Human papillomavirus is more prevalent in first trimester spontaneously aborted products of conception compared to elective specimens. Virus Genes 1997;14:13-7.
10. Eppel W, Worda C, Frigo P, Ulm M, Kucera E, Czerwenka K. Human papillomavirus in the cervix and placenta. Obstet Gynecol 2000;96:337-41.
11. Smith E, Johnson SR, Cripe T, Perlman S, McGuinness G, Jiang D, et al. Perinatal transmission and maternal risks of human papillomavirus infection. Cancer Detect Prev 1995;19:196-205.
12. Tenti P, Zappatore R, Migliora P, Spinillo A, Belloni C, Carnevali L. Perinatal transmission of human papillomavirus from gravidas with latent infections. Obstet Gynecol 1999;93:475-9.
13. Puranen M, Yliskoski MH, Saarikoski SV, Syrjanen KJ, Syrjanen SM. Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood. Am J Obstet Gynecol 1996;174:694-9.
14. Cason J. Perinatal acquisition of cervical cancer-associated papillomaviruses. Br J Obstet Gynaecol 1996;103:853-8.
15. Yell JA, Sinclair R, Mann S, Fleming K, Ryan TJ. Human papillomavirus type 6-induced condylomata: an unusual complication of intertrigo. Br J Dermatol 1993;128:575-7.
16. Cason J, Kaye JN, Jewers RJ, Kambo PK, Bible JM, Kell B, et al. Perinatal infection and persistence of human papillomavirus types 16 and 18 in infants. J Med Virol 1995;47:209-218.